175 related articles for article (PubMed ID: 19100858)
41. Vav1 acidic region tyrosine 174 is required for the formation of T cell receptor-induced microclusters and is essential in T cell development and activation.
Miletic AV; Sakata-Sogawa K; Hiroshima M; Hamann MJ; Gomez TS; Ota N; Kloeppel T; Kanagawa O; Tokunaga M; Billadeau DD; Swat W
J Biol Chem; 2006 Dec; 281(50):38257-65. PubMed ID: 17050525
[TBL] [Abstract][Full Text] [Related]
42. Vav1 accelerates Ras-driven lung cancer and modulates its tumor microenvironment.
Shalom B; Farago M; Salaymeh Y; Sebban S; Risling M; Pikarsky E; Katzav S
Cell Signal; 2022 Sep; 97():110395. PubMed ID: 35752351
[TBL] [Abstract][Full Text] [Related]
43. Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion.
Sebban S; Farago M; Rabinovich S; Lazer G; Idelchuck Y; Ilan L; Pikarsky E; Katzav S
Oncotarget; 2014 Oct; 5(19):9214-26. PubMed ID: 25313137
[TBL] [Abstract][Full Text] [Related]
44. An active form of Vav1 induces migration of mammary epithelial cells by stimulating secretion of an epidermal growth factor receptor ligand.
Wilsbacher JL; Moores SL; Brugge JS
Cell Commun Signal; 2006 May; 4():5. PubMed ID: 16709244
[TBL] [Abstract][Full Text] [Related]
45. Molecular basis for failure of "atypical" C1 domain of Vav1 to bind diacylglycerol/phorbol ester.
Geczy T; Peach ML; El Kazzouli S; Sigano DM; Kang JH; Valle CJ; Selezneva J; Woo W; Kedei N; Lewin NE; Garfield SH; Lim L; Mannan P; Marquez VE; Blumberg PM
J Biol Chem; 2012 Apr; 287(16):13137-58. PubMed ID: 22351766
[TBL] [Abstract][Full Text] [Related]
46. Vav1 Promotes B-Cell Lymphoma Development.
Shalom B; Farago M; Salaymeh Y; Sebban S; Pikarsky E; Katzav S
Cells; 2022 Mar; 11(6):. PubMed ID: 35326399
[TBL] [Abstract][Full Text] [Related]
47. Phosphatidylinositol Monophosphates Regulate Optimal Vav1 Signaling Output.
Rodríguez-Fdez S; Citterio C; Lorenzo-Martín LF; Baltanás-Copado J; Llorente-González C; Corbalán-García S; Vicente-Manzanares M; Bustelo XR
Cells; 2019 Dec; 8(12):. PubMed ID: 31888228
[TBL] [Abstract][Full Text] [Related]
48. Vav1 as a central regulator of invadopodia assembly.
Razidlo GL; Schroeder B; Chen J; Billadeau DD; McNiven MA
Curr Biol; 2014 Jan; 24(1):86-93. PubMed ID: 24332539
[TBL] [Abstract][Full Text] [Related]
49. Vav1 GEF activity is required for T cell mediated allograft rejection.
Haubert D; Li J; Saveliev A; Calzascia T; Sutter E; Metzler B; Kaiser D; Tybulewicz VL; Weckbecker G
Transpl Immunol; 2012 Jun; 26(4):212-9. PubMed ID: 22456277
[TBL] [Abstract][Full Text] [Related]
50. Regulatory interplay between Vav1, Syk and β-catenin occurs in lung cancer cells.
Boudria R; Laurienté V; Oudar A; Harouna-Rachidi S; Dondi E; Le Roy C; Gardano L; Varin-Blank N; Guittat L
Cell Signal; 2021 Oct; 86():110079. PubMed ID: 34252536
[TBL] [Abstract][Full Text] [Related]
51. Lysine Acetylation Reshapes the Downstream Signaling Landscape of Vav1 in Lymphocytes.
Rodríguez-Fdez S; Fernández-Nevado L; Lorenzo-Martín LF; Bustelo XR
Cells; 2020 Mar; 9(3):. PubMed ID: 32143292
[TBL] [Abstract][Full Text] [Related]
52. Function of the nucleotide exchange activity of vav1 in T cell development and activation.
Saveliev A; Vanes L; Ksionda O; Rapley J; Smerdon SJ; Rittinger K; Tybulewicz VL
Sci Signal; 2009 Dec; 2(101):ra83. PubMed ID: 20009105
[TBL] [Abstract][Full Text] [Related]
53. Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1.
Yu B; Martins IR; Li P; Amarasinghe GK; Umetani J; Fernandez-Zapico ME; Billadeau DD; Machius M; Tomchick DR; Rosen MK
Cell; 2010 Jan; 140(2):246-56. PubMed ID: 20141838
[TBL] [Abstract][Full Text] [Related]
54. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
[TBL] [Abstract][Full Text] [Related]
55. The C1 domain of Vav3, a novel potential therapeutic target.
Kelsey JS; Géczy T; Kaler CJ; Blumberg PM
Cell Signal; 2017 Dec; 40():133-142. PubMed ID: 28927664
[TBL] [Abstract][Full Text] [Related]
56. Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma.
Fujisawa M; Sakata-Yanagimoto M; Nishizawa S; Komori D; Gershon P; Kiryu M; Tanzima S; Fukumoto K; Enami T; Muratani M; Yoshida K; Ogawa S; Matsue K; Nakamura N; Takeuchi K; Izutsu K; Fujimoto K; Teshima T; Miyoshi H; Gaulard P; Ohshima K; Chiba S
Leukemia; 2018 Mar; 32(3):694-702. PubMed ID: 28832024
[TBL] [Abstract][Full Text] [Related]
57. Alteration of the PKC theta-Vav1 complex and phosphorylation of Vav1 in TCDD-induced apoptosis in the lymphoblastic T cell line, L-MAT.
Ishida M; Itsukaichi T; Kobayashi D; Kikuchi H
Toxicology; 2010 Sep; 275(1-3):72-8. PubMed ID: 20561557
[TBL] [Abstract][Full Text] [Related]
58. Vav2 lacks Ca
Fray MA; Charpentier JC; Sylvain NR; Seminario MC; Bunnell SC
J Cell Sci; 2020 Mar; 133(5):. PubMed ID: 31974114
[TBL] [Abstract][Full Text] [Related]
59. An efficient method for protein phosphorylation using the artificially introduced of cognate-binding modules into kinases and substrates.
Kobashigawa Y; Naito M; Inagaki F
J Biotechnol; 2007 Sep; 131(4):458-65. PubMed ID: 17875337
[TBL] [Abstract][Full Text] [Related]
60. The distinct role of guanine nucleotide exchange factor Vav1 in Bcl-2 transcription and apoptosis inhibition in Jurkat leukemia T cells.
Yin J; Wan YJ; Li SY; Du MJ; Zhang CZ; Zhou XL; Cao YJ
Acta Pharmacol Sin; 2011 Jan; 32(1):99-107. PubMed ID: 21151158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
